Laboratory Corporation of America Holdings (LH) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Diagnostics & Research industry.
Over the past 4 years, Laboratory Corporation of America Holdings has achieved a revenue compound annual growth rate (CAGR) of -1.8%, while earnings have grown at -16.8% CAGR.
Historical revenue and profitability trends for Laboratory Corporation of America Holdings
The chart above illustrates Laboratory Corporation of America Holdings's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Laboratory Corporation of America Holdings's business.
How efficiently Laboratory Corporation of America Holdings converts revenue into profit
Profit margins reveal how much of each dollar of revenue Laboratory Corporation of America Holdings retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Laboratory Corporation of America Holdings to continue growing earnings in the coming year. The consensus analyst rating is 4.45 based on 20 analysts.
Based on our comprehensive analysis, Laboratory Corporation of America Holdings (LH) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Laboratory Corporation of America Holdings's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Laboratory Corporation of America Holdings stacks up against similar companies
Explore growth analysis for top stocks
Related: LH Valuation, LH Dividend, LH Financial Health
Compare: LH vs AAPL, LH vs MSFT, LH vs GOOGL